Health
Johnson & Johnson COVID-19 vaccine linked to potentially paralysing Guillain-Barré syndrome – 7NEWS.com.au
Just weeks ago, the TGA granted the vaccine provisional approval for use in Australia.
There are fears some recipients of Johnson & Johnsons coronavirus vaccine face an increased risk of a rare neurological complication known as Guillain-Barre syndrome (GBS) after an increase in reports of the sometimes paralysing condition.
The US Food and…
Continue Reading
-
Noosa News22 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
General18 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General11 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore
-
General21 hours agoSussan Ley’s office says Bridget McKenzie made false claims about cabinet solidarity